Aug 10, 2026 04:05PM
Aug 10, 2026 04:05PM
Aug 5, 2026 04:05PM
Aug 5, 2026 04:05PM
Jul 15, 2026 04:05PM
Jul 15, 2026 04:05PM
Jul 14, 2026 04:07PM Qiagen launches new bloodstream infection panel in Europe
Jul 14, 2026 04:05PM
Jun 15, 2026 02:58AM
Jun 15, 2026 01:30AM
May 28, 2026 04:06PM
May 28, 2026 04:05PM
May 20, 2026 04:07PM
May 20, 2026 04:05PM QIAGEN launches QIA Agent, connecting AI-driven scientific guidance across Sample to Insight workflows
May 19, 2026 04:05PM
May 19, 2026 04:05PM
May 12, 2026 02:00AM
May 7, 2026 06:01AM
May 7, 2026 06:00AM
May 6, 2026 04:05PM
Apr 27, 2026 04:16PM QIAGEN lowers 2026 outlook as QuantiFERON immigration testing drops
Apr 27, 2026 04:16PM
Apr 16, 2026 04:05PM
Apr 14, 2026 04:05PM
Apr 14, 2026 04:05PM
Mar 19, 2026 04:05PM
Mar 10, 2026 05:05PM
Feb 19, 2026 08:00AM Parse Biosciences Launches Evercode Whole Transcriptome V4 With Shorter Workflow, Higher Sensitivity and Higher Cell Recovery
Feb 4, 2026 04:05PM
Feb 3, 2026 04:05PM
Jan 26, 2026 04:05PM
Jan 26, 2026 04:05PM
Jan 12, 2026 02:00AM
Dec 18, 2025 11:27AM
Dec 18, 2025 11:27AM QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $500 Million
Nov 10, 2025 01:30AM
Nov 4, 2025 01:04PM
Nov 4, 2025 01:04PM
Aug 5, 2025 04:05PM
Jun 26, 2025 01:16PM
Jun 26, 2025 01:16PM
May 7, 2025 04:05PM QIAGEN delivers solid Q1 2025 results exceeding outlook; will seek shareholder approval to initiate a dividend and new $500 mn repurchase
Feb 5, 2025 04:05PM
Jan 16, 2025 04:05PM
Jan 12, 2025 01:05PM
Nov 3, 2021 04:08PM
Jul 29, 2021 04:14PM
Jul 12, 2021 11:16AM
Jul 12, 2021 11:15AM QIAGEN announces preliminary Q2 2021 results exceeding outlook, updates full-year 2021 outlook for declining COVID-19 test trends and plans new $100 million share repurchase program
Mar 2, 2020 08:19AM

102,067 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All